Idelalisib is a phosphoinositide 3-kinase (PI3K) inhibitor used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and follicular lymphoma. By blocking PI3K, it inhibits the signaling pathways that promote cancer cell survival and proliferation, leading to cancer cell death. It is usually administered orally.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Idelalisib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Idelalisib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Idelalisib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
